![2-[6-(Bis(Carboxymethyl)Amino)-5-[2-[6-(Bis(Carboxymethyl)Amino)-2,3-Difluorophenoxy]Ethoxy]-2-Ben…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFB103907.webp&w=3840&q=75)
2-[6-(Bis(Carboxymethyl)Amino)-5-[2-[6-(Bis(Carboxymethyl)Amino)-2,3-Difluorophenoxy]Ethoxy]-2-Benzofuran-1-Yl]-1,3-Oxazole-5-Carbox ylic Acid
CAS:
Rif. 3D-FB103907
Informazioni sul prodotto
Nome:2-[6-(Bis(Carboxymethyl)Amino)-5-[2-[6-(Bis(Carboxymethyl)Amino)-2,3-Difluorophenoxy]Ethoxy]-2-Benzofuran-1-Yl]-1,3-Oxazole-5-Carbox ylic Acid
Marchio:Biosynth
Descrizione:2-[6-(Bis(Carboxymethyl)Amino)-5-[2-[6-(Bis(Carboxymethyl)Amino)-2,3-Difluorophenoxy]Ethoxy]-2-Benzofuran-1-Yl]-1,3-Oxazole-5-Carbox ylic Acid (CAF01) is a small molecule that has been shown to have neuroprotective effects in animal models of stroke. It prevents neuronal death by inhibiting the release of glutamate and cytosolic calcium levels. CAF01 also inhibits intracellular calcium overload and mitochondrial membrane potential. It protects cells from ischemic brain damage by maintaining the function of neurons and ATP production. CAF01 is a high resistance compound with good bioavailability in vivo.br>
br>
CAF01 is being developed as a treatment for stroke patients who are at high risk of recurrent stroke or death due to cerebral infar
Avviso:I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Proprietà chimiche
Peso molecolare:663.49 g/mol
Formula:C28H23F2N3O14
Purezza:Min. 95%